Good Distribution Practices

Good distribution practices ensure maintaining product safety and quality during distribution across the supply chain and this practice is of significant  importance for the pharmaceutical industry. Good Distribution Practices (GDP) Compliance report for Pharmaceutical Industry demonstrates Quality commitment & sound practices in the entire pharmaceutical distribution supply chain.

Managing quality of medicines during distribution is a challenging operation. The challenges of the pharmaceutical products supply chain is and due to its specified shelf life and storage conditions. The various dosage forms (eg tablets, syrups, injectables etc.) are to be transported and stored at different environmental conditions hence all medicines cannot be handled with a general rule. viz the requirement of handling tablets, syrups and injectables shall widely vary.

Cold chain product range of medicines are stored at temperature between 2 to 8 O C. For cold chain products, therefore the degree of carefulness shall be more due to the fear of product failures during quality control testing by customers. The GDP guidelines are intended to be applicable to all persons and outlets involved in any aspect of the storage and distribution of pharmaceutical products from the premises of the manufacturer of the product to the person dispensing or providing pharmaceutical products directly to a patient or his or her agent.

This scheme ensures that consistent quality management systems are in place throughout your entire supply chain, from the early delivery of raw materials to the manufacturing plants, to the final shipment of finished drugs to the end user. Good Distribution Practices (GDP) is a quality system for warehouse and distribution centres dedicated for medicines. Internationally accepted pharmaceutical GDP regulations stipulate that distributors of pharmaceutical products must align their operations with the standards.

The Indian Government has issued a consolidated paper through Central Drugs Standards Control Organization (CDSCO) on good distribution practices (GDP) for pharmaceutical products to ensure the quality and identity of pharmaceutical products during all aspects of the distribution process like procurement, purchasing, storage, distribution, transportation, documentation and record-keeping practices.

We help pharmaceutical companies involved in developing complex molecules through every stage of their new product development process and lifecycle, our global services and solutions enhance your end to end manufacturing processes, providing you with the confidence that you are optimising the time to market, whilst ensuring patient safety. We help your performance and protect your brand and business reputation, safeguarding patients, profitability and shareholder value.

Get an independent assessment of compliance against international GDP requirements is the most effective way to establish that your quality management system aligns with GDP compliance.